Jan 27, 2016 13:02 pm UTC| Business
Albany, NY , Jan. 27, 2016 -- The report provides historical data for last few years and presents projections for the years between 2014 and 2020. The report presents an overview of the key driving and restraining...
Sigma Labs and 3DSIM Sign Technology Development Agreement for Metal AM
Jan 27, 2016 13:00 pm UTC| Business
SANTA FE, N.M., Jan. 27, 2016 -- Sigma Labs, Inc. (OTCQB:SGLB) (“Sigma Labs” or the “Company”), a developer of advanced, in process, non-destructive quality inspection systems for metal-based additive manufacturing...
O2Micro Reports Fourth Quarter and Fiscal 2015 Financial Results
Jan 27, 2016 13:00 pm UTC| Business
GEORGE TOWN, Grand Cayman, Jan. 27, 2016 -- Operational and Strategic Highlights: O2Micro continues to lower operating expenses. Company lowers fiscal year 2015 operating expenses by $7.4 million on a year-over-year...
Fibrocell Highlights Recent Pipeline Accomplishments
Jan 27, 2016 13:00 pm UTC| Business
Patient Dosing in Phase II Trial of azficel-T for Chronic Dysphonia CompletedPreclinical Toxicology Study for FCX-007 InitiatedPositive POC Data Shows FCX-013 Reduces Dermal Thickness of Fibrotic Tissue EXTON, Pa., Jan. ...
Depomed Announces Save the Date for 2016 Analyst and Investor Day
Jan 27, 2016 13:00 pm UTC| Business
NEWARK, Calif., Jan. 27, 2016 -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will hold an Analyst and Investor Day in New York City on Wednesday, March 23, 2016 from 9:00 a.m. ET – 11:30 a.m. ET (6:00 a.m. PT –...
Pacific Mercantile Bank Expands Small Business Lending Programs
Jan 27, 2016 13:00 pm UTC| Business
COSTA MESA, Calif., Jan. 27, 2016 -- Pacific Mercantile Bank (“the Bank”), the wholly owned subsidiary of Pacific Mercantile Bancorp (NASDAQ:PMBC), today announced that it is now participating in the California State...
Recro Pharma Initiates Pivotal Phase III Clinical Trial of IV Meloxicam for Acute Postoperative Pain
Jan 27, 2016 13:00 pm UTC| Business
MALVERN, Pa., Jan. 27, 2016 -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company developing multiple non-opioid therapeutics for the treatment of pain, today announced that the...
South Africa’s plan to move away from coal: 8 steps to make it succeed
Germany lowers voting age to 16 for the European elections
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects